Document Detail

Valproic acid inhibits proliferation and changes expression of CD44 and CD56 of malignant glioma cells in vitro.
MedLine Citation:
PMID:  9858943     Owner:  NLM     Status:  MEDLINE    
Recently we were able to show that valproic acid (VPA) induces growth-arrest and differentiation of human neuroblastoma cells. Hence we investigated in vitro the antitumoral effects of VPA on malignant gliomas by determining cell proliferation and expression of CD56 and CD44 of human T98G, A172, 85HG66, 86HG39 and rat C6 cell lines. VPA at concentrations ranging from 0.1 to 1 mM strongly inhibited proliferation of A172, 86HG39, 85HG66 and C6 cells in a dose-dependent manner, whereas T98G cell growth remained unchanged. All human glioma cells were highly positive for CD44, whereas CD56 was differently expressed. After 7 days of incubation with 1mM VPA CD56 expression was markedly increased in T98G, A172 and 85HG66 cells, whereas CD44 expression was decreased in all human cell lines. These data suggest that VPA has antitumoral effects on malignant glioma cells. Therefore we consider VPA as a potent therapeutic agent for treatment of these tumors.
M M Knüpfer; P Hernáiz-Driever; H Poppenborg; J E Wolff; J Cinatl
Related Documents :
10676633 - Constitutive activation of cyclin b1-associated cdc2 kinase overrides p53-mediated g2-m...
20118823 - Blocking angiotensin ii type 1 receptor triggers apoptotic cell death in human pancreat...
20307653 - Evidence that yeast frataxin is not an iron storage protein in vivo.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Anticancer research     Volume:  18     ISSN:  0250-7005     ISO Abbreviation:  Anticancer Res.     Publication Date:    1998 Sep-Oct
Date Detail:
Created Date:  1998-12-29     Completed Date:  1998-12-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  GREECE    
Other Details:
Languages:  eng     Pagination:  3585-9     Citation Subset:  IM    
University Hospital, Department of Pediatric Hematology and Oncology, Leipzig, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antigens, CD44 / metabolism
Antigens, CD56 / metabolism
Antineoplastic Agents / pharmacology*
Biological Markers
Cell Division / drug effects
Cell Survival / drug effects
Drug Screening Assays, Antitumor
Glioma / drug therapy*,  metabolism
Tumor Cells, Cultured / drug effects
Valproic Acid / pharmacology*
Reg. No./Substance:
0/Antigens, CD44; 0/Antigens, CD56; 0/Antineoplastic Agents; 0/Biological Markers; 99-66-1/Valproic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Resistance to apoptosis and cyclooxygenase-2 expression in a human adenocarcinoma cell line HT29 CL....
Next Document:  Effect of 4-hydroxynonenal, a product of lipid peroxidation, on NK susceptibility of human K562 targ...